Galapagos NV

1.82% €26.9

17:30 – 15/05/2024

Nieuws van Galapagos NV

Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript

Bron: Yahoo Entertainment

Gepubliceerd op: 2024-05-06

Galapagos : Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Bron: Marketscreener.com

Gepubliceerd op: 2024-05-01

(marketscreener.com) Galapagos NV Galapagos NV Below you will find information from the register publication of inside information. The information has been provided by the organisation. Registration date30 apr 2024 – 22:07 Statutory…

Galapagos : Galapagos reports first quarter 2024 financial results

Bron: Marketscreener.com

Gepubliceerd op: 2024-05-03

(marketscreener.com) Galapagos NV Galapagos NV Below you will find information from the register publication of inside information. The information has been provided by the organisation. Registration date02 may 2024 – 22:14 Statutory…

Galapagos NV (NASDAQ:GLPG) Short Interest Update

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-05-02

Galapagos NV (NASDAQ:GLPG – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 1,500,000 shares, an increase of 5.6% from the March 31st total of 1,420,000 shares. Based on a…

Galapagos NV Reports Strong Q1 2024 Financials

Bron: Biztoc.com

Autheur: tipranks.com

Gepubliceerd op: 2024-05-03

has released an update. Galapagos NV shared positive first quarter financial results for 2024, with net revenues rising to €62…. #galapagosnv

Galapagos NV Shareholders Approve Key Resolutions

Bron: Biztoc.com

Autheur: tipranks.com

Gepubliceerd op: 2024-05-01

has released an update. Galapagos NV, the Belgium-based biotech company, has announced that its shareholders have approved all … #galapagosnv #belgium

Citi lowers Galapagos NV shares target amid restructuring and pipeline investments

Bron: Investing.com

Autheur: Investing.com

Gepubliceerd op: 2024-04-17

Citi lowers Galapagos NV shares target amid restructuring and pipeline investments

Galapagos NV (NASDAQ:GLPG) Receives Average Recommendation of “Hold” from Analysts

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-05-04

Galapagos NV (NASDAQ:GLPG – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five brokerages that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating,…

Signaturefd LLC Purchases 867 Shares of Galapagos NV (NASDAQ:GLPG)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-05-01

Signaturefd LLC raised its position in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 78.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,970 shares of the biotechn…

Galapagos (NASDAQ:GLPG) Reaches New 52-Week Low at $29.45

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-04-18

Shares of Galapagos NV (NASDAQ:GLPG – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $29.45 and last traded at $29.49, with a volume of 16106 shares. The stock had previously closed at $29.80. Analyst Upgrades and Downgra…

Head to Head Analysis: Galapagos (NASDAQ:GLPG) vs. Vivesto (OTCMKTS:OASMY)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-04-22

Vivesto (OTCMKTS:OASMY – Get Free Report) and Galapagos (NASDAQ:GLPG – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuat…

Head-To-Head Survey: Galapagos (NASDAQ:GLPG) & Precigen (NASDAQ:PGEN)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-04-30

Galapagos (NASDAQ:GLPG – Get Free Report) and Precigen (NASDAQ:PGEN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institu…

Galapagos (NASDAQ:GLPG) Receives “Equal Weight” Rating from Morgan Stanley

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-04-24

Galapagos (NASDAQ:GLPG – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Morgan Stanley in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $38.00 price targe…

Oxurion : Statutory auditor’s report to the general shareholders’ meeting of Oxurion NV on the annual accounts for the year ended 31 December 2023

Bron: Marketscreener.com

Gepubliceerd op: 2024-04-16

(marketscreener.com) STATUTORY AUDITOR’S REPORT TO THE GENERAL SHAREHOLDERS’ MEETING OF OXURION NV ON THE ANNUAL ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2023 We present to you our statutory auditor’s report in the context of our statutory audit of th…

E-therapeutics plc shares now trading on JP Jenkins

Bron: Marketscreener.com

Gepubliceerd op: 2024-05-09

(marketscreener.com) JP Jenkins Ltd e-therapeutics plc shares now trading on JP Jenkins 09-May-2024 / 07:30 GMT/BST The issuer is solely responsible for the content of this announcement. 9th May 2024 JPJ: ETX ISIN: GB00B2823H99   …

Global Medical Dynamometers Market to Witness Upsurge in Growth at a CAGR of ~6% by 2030 | DelveInsight

Bron: PR Newswire UK

Gepubliceerd op: 2024-04-30

The medical dynamometers market is predicted to surge owing to the rise in bone-related conditions like osteoporosis and arthritis, along with an uptick in sports injuries and the expanding elderly demographic. LAS VEGAS, April 30, 2024 /PRNewswire/ — DelveI…

Oxurion : Annual Report of the Board of Directors on the statutory accounts for the FY 2023

Bron: Marketscreener.com

Gepubliceerd op: 2024-04-15

(marketscreener.com) Annual Report of the Board of Directors on the Statutory Financial Statements Dear Shareholder, We are pleased to present the annual accounts as at December 31, 2023. Comments to Statutory Accounts The 2023 financi…

Gilead Sciences (NASDAQ:GILD) and Mesoblast (NASDAQ:MESO) Critical Contrast

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-04-22

Gilead Sciences (NASDAQ:GILD – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, earnings, valuation, ins…

Cystic Fibrosis Market Pipeline Insights Report 2024 Featuring 75+ Companies and 80+ Pipeline Drugs, Including VX-121 (Vertex Pharma), Brensocatib (AstraZeneca), ELX-02 (Eloxx Pharma), and S-1226 (SolAeroMed)

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2024-04-16

Dublin, April 16, 2024 (GLOBE NEWSWIRE) — The “Cystic Fibrosis – Pipeline Insight, 2024” drug pipelines has been added to ResearchAndMarkets.com’s offering.This report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Cystic Fibro…

Scroll naar boven